The comparison of P (EUR) and EA to medications used in the treatment of MS.

Figshare2017-02-28 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/The_comparison_of_P_EUR_and_EA_to_medications_used_in_the_treatment_of_MS_/4699318 数据链接链接失效反馈

官方服务：

资源简介：

The comparison of P (EUR) and EA to medications used in the treatment of MS.

创建时间：

2017-02-28

Custo-efetividade do Monlupiravir contra infecção de COVID-19 em pacientes idosos e imunossurpimidos [Cost-effectiveness of Monlupiravir against COVID-19 infection in elderly and immunosuppressed patients]

药物经济学评估

卫生技术评估

Trata-se do repositório de versões do modelo completo de análise de custo-efetividade do Monlupiravir contra infecção de COVID-19 em pacientes idosos e imunossurpimidos elaborado pelo Núcleo de Avali

NIAID Data Ecosystem80

Characteristics of the study cohort at the index date overall and by the initial DMT prescribed.

多发性硬化症治疗

疾病修饰疗法疗效评估

GA = glatiramer acetate; IFN-β = interferon-beta; EDSS = Expanded Disability Status Scale; y = years.aIFN-β-1a s.c. (n = 411), IFN-β-1b (n = 120), IFN-β-1a i.m. (n = 34).bMissing in 6 patients; of 8 p

Figshare2015-12-03 更新50

Dataset from Open-Label, Multicenter, Multiple-Dose Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis Aged 10 to 17 Years

多发性硬化症治疗

药物动力学评估

The primary objective of this study is to evaluate the effect of BG00012 (dimethyl fumarate) on brain magnetic resonance imaging (MRI) lesions in pediatric participants with relapsing-remitting multip

NIAID Data Ecosystem40

Association between SES and access to a second-line DMT for RRMS patients after a 5-years delay between first and second line DMT.

医疗资源公平性

多发性硬化症治疗

Association between SES and access to a second-line DMT for RRMS patients after a 5-years delay between first and second line DMT.

NIAID Data Ecosystem60

Difference in use of drugs used to treat MS symptoms in defined daily doses (DDD) two years before and after initiation of LDN therapy by number of LDN dispenses to patient.

多发性硬化症治疗

药物使用模式分析

Difference in use of drugs used to treat MS symptoms in defined daily doses (DDD) two years before and after initiation of LDN therapy by number of LDN dispenses to patient.

Figshare2017-11-04 更新40

The comparison of P (EUR) and EA to medications used in the treatment of MS.

资源简介：

相关数据集